Cognitive enhancers: unfair at any dose?
How should universities tackle the use of cognitive enhancement drugs by students? Professor Barbara Sahakian raised the issue in a recent talk. While hard numbers are hard to come by, it is likely that at least a few percent of university students take drugs believed to improve cognitive ability. This may give them advantages that could be unfair (if some have access while others haven't) or would have coercive effects (if you don't take the drug but your classmates are, you will be at a disadvantage). Are enhancer use among students inherently unfair and coercive?
